Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
A Window of Opportunity Clinical Trial. This study design permits examination of effects of
an oral agent on cancer patients during the "window" between diagnosis of their cancer and
their definitive cancer surgery. Similar to a phase 0 study, the trial design permits
examination of the biologic effects of an agent; in this study pharmacokinetic properties
will be examined.